AC Immune (ACIU) Cash & Current Investments (2014 - 2026)
AC Immune's Cash & Current Investments came in at $95.34 million for the quarter ended Jun 30, 2026, down 37.9% from $153.57 million a year earlier and down 0.2% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Cash & Current Investments (2014 - 2026) Analysis & Trends
As of Dec 31, 2025, AC Immune's Cash & Current Investments was $110.25 million, down 41.4% from the prior year.
- Cash & Current Investments carries a five-year compound annual growth rate of -14.5% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Current Investments was $188.11 million in the year ended Dec 31, 2024 (+16.6%), $161.38 million in the year ended Dec 31, 2023 (+25.6%), $128.5 million in the year ended Dec 31, 2022 (-40.8%) and $216.92 million in the year ended Dec 31, 2021 (-9.9%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Cash & Current Investments since the quarter ended Sep 30, 2023.
- Year-over-year, Cash & Current Investments has declined for five consecutive quarters, with an average decline of 1.6% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in the quarter ended Dec 31, 2023 (growth of 178.2%), and the weakest in the quarter ended Dec 31, 2021 (a decline of 84.0%).
- Business Quant data shows ACIU's Cash & Current Investments at $95.52 million (quarter ended Mar 31, 2026), $114.37 million (quarter ended Dec 31, 2025) and $135.6 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | AC Immune | 246.22 Mn | -192.18 Mn | - | 93.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.36 Mn |
| Mar 31, 2026 | 93.51 Mn |
| Dec 31, 2025 | 115.46 Mn |
| Sep 30, 2025 | 136.06 Mn |
| Jun 30, 2025 | 159.27 Mn |
| Mar 31, 2025 | 165.31 Mn |
| Dec 31, 2024 | 183.22 Mn |
| Sep 30, 2024 | 187.86 Mn |
| Jun 30, 2024 | 194.90 Mn |
| Mar 31, 2024 | 116.33 Mn |
| Dec 31, 2023 | 122.19 Mn |
| Sep 30, 2023 | 87.37 Mn |
| Jun 30, 2023 | 103.44 Mn |
| Mar 31, 2023 | 115.43 Mn |
| Dec 31, 2022 | 132.83 Mn |
| Sep 30, 2022 | 144.12 Mn |
| Jun 30, 2022 | 161.55 Mn |
| Mar 31, 2022 | 188.34 Mn |
| Dec 31, 2021 | 216.94 Mn |
| Sep 30, 2021 | 201.86 Mn |
API Access
AC Immune Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();